Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 65 and up Women only

Precision management of urinary tract symptoms in older women

Official title: Precision Management of Urinary Tract Symptoms in Older Women: A Randomized Trial to Reduce Overtreatment

Run by University of Pittsburgh · NCT07686055 · Data updated 2026-11-12

This trial tests three ways to treat urinary tract symptoms in women 65 and older to see which approach works best and minimizes unnecessary antibiotic use.

Quick facts

PhasePhase 3
Study typeInterventional
Ages65 Years and up
SexWomen only
Enrollment90 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Drugs / interventionsprednisone
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedJuly 23, 2026
Main results expectedFebruary 1, 2027
Study endsFebruary 14, 2027
Registry record updatedOctober 22, 2026
Trial IDNCT07686055 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 65 or older with a history of recurrent UTIs who experience current UTI symptoms as defined by dysuria, urgency/frequency, or suprapubic pain.

Probably not a fit

Patients unlikely to benefit may include those with non-UTI causes of symptoms or with complex comorbidities that affect outcomes.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 3 randomized trial compares empiric antibiotics, urinalysis-guided therapy, and culture-directed care for urinary tract symptoms in women aged 65 and older with a history of recurrent UTIs. Participants are enrolled from UPMC and a research registry and followed for 28 days after randomization. The study combines patient-reported outcomes with laboratory data to determine which strategy benefits patients the most while supporting antibiotic stewardship. The goal is to identify precision care pathways that improve symptoms and quality of life in a high-risk population. Results could guide more targeted, effective management of recurrent UTIs in older women.

Why it matters

Potential benefit: If successful, the trial could identify which patients can avoid unnecessary antibiotics without compromising symptom control.

How similar studies have gone: Prior studies have explored targeted antibiotic strategies, but this trial advances precision care by directly comparing three management approaches in a high-risk, older population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female biologic Sex
* Age ≥65 years old
* History of recurrent UTI per patient report of greater than 2 UTIs in the last 6 months or 3 UTIs in the last year
* Patient reported UTI defined as:

  * Dysuria, increased urinary urgency/frequency and/or suprapubic pain

Exclusion Criteria:

* Male biologic sex
* Age \<65 years old
* History of augmentation cystoplasty or cystectomy
* Currently performing clean intermittent self-catheterization
* Current indwelling foley catheter
* Urinary tract instrumentation (i.e., cystourethroscopy, foley catheter placement) in the last 30 days
* Undergoing treatment for malignancy
* History of either confirmed or patient reported pyelonephritis and/or urosepsis
* Cirrhosis and/or end stage liver disease
* Chronic kidney disease with most recent estimated glomerular filtration rate \<50 ml/min
* Dementia and/or currently reside in skilled nursing facility
* Current high-dose chronic steroids (\>20mg/day of prednisone)
* Previous solid organ transplant
* Provider concern for pyelonephritis and/or sepsis (i.e., fevers)
* Unwilling or unable to comply with study procedures (including ability to complete electronic questionnaires)

Where it's running

  • UPMC-Magee Womens Hospital
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Megan Bradley, MD, MSc — University of Pittsburgh
  • Study coordinator: Megan S Bradley, MD MSc
  • Email: bradleym4@upmc.edu
  • Phone: 412-641-7850

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.